FDA actions against Indian pharma raise concerns among U.S. docs

03/18/2014 | Reuters

Import bans by the U.S. FDA and recalls are prompting concerns among U.S. doctors regarding the quality of generic drugs from Indian drugmakers. Drugs produced elsewhere have also been recalled over safety issues, but the issue is of particular concern because many generics are produced by Indian companies, and use of generics is an important cost-saving mechanism.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care